Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosis

There is a paucity of clinical trials evaluating prophylactic antibiotics in patients with interstitial lung disease, although Enomoto et al 4 showed a benefit with co-trimoxazole prophylaxis against Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia receiving high-dose glucocor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thorax 2013-09, Vol.68 (9), p.884-885
Hauptverfasser:	Shulgina, Ludmila, Cahn, Anthony P, Chilvers, Edwin R, Parfrey, Helen, Clark, Allan B, Wilson, Edward C F, Twentyman, Orion P, Davison, Anthony G, Curtin, John J, Crawford, Michael B, Wilson, Andrew M
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents - therapeutic use Female Humans Idiopathic Pulmonary Fibrosis - drug therapy Infections Interstitial Fibrosis Male Mortality Pneumonia Pulmonary fibrosis Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There is a paucity of clinical trials evaluating prophylactic antibiotics in patients with interstitial lung disease, although Enomoto et al 4 showed a benefit with co-trimoxazole prophylaxis against Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia receiving high-dose glucocorticoid therapy.
ISSN:	0040-6376 1468-3296
DOI:	10.1136/thoraxjnl-2013-203765